The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry (Q33425754)

26 July 2017

title

The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry (English)

1 reference

26 July 2017

Sevda Hassan

1

0 references

Marie Scully

7

object named as

Marie Scully

1 reference

26 July 2017

John-Paul Westwood

2

1 reference

26 July 2017

Debra Ellis

3

1 reference

26 July 2017

Chris Laing

4

1 reference

26 July 2017

Siobhan Mc Guckin

5

1 reference

26 July 2017

Sylvia Benjamin

6

1 reference

26 July 2017

language of work or name

English

0 references

publication date

11 September 2015

1 reference

British Journal of Haematology

26 July 2017

published in

1 reference

26 July 2017

volume

171

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

830-835

1 reference

Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange

26 July 2017

cites work

1 reference

Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience

21 January 2018

1 reference

Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease.

21 January 2018

1 reference

Genetics and complement in atypical HUS.

21 January 2018

1 reference

FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay

21 January 2018

1 reference

Atypical hemolytic uremic syndrome

21 January 2018

1 reference

Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency

21 January 2018

1 reference

How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome

21 January 2018

1 reference

Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.

21 January 2018

1 reference

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies

21 January 2018

1 reference

Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.

21 January 2018

1 reference

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.13654

1 reference

26 July 2017

1 reference